⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for antimitotic agent

Every month we try and update this database with for antimitotic agent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung CancerNCT02087176
Previously Trea...
AZD1775
AZD1775 Placebo
Antimitotic Age...
pegfiligrastim
18 Years - AstraZeneca
Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line TreatmentNCT02061085
Breast Neoplasm
Metastasis
Eribulina
18 Years - MedSIR
Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line TreatmentNCT02061085
Breast Neoplasm
Metastasis
Eribulina
18 Years - MedSIR
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: